Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA).
Massimo BrecciaPier Paolo OlimpieriSimone CelantOdoardo Maria OlimpieriFabrizio PaneAlessandra IurloValentina SummaPaolo CorradiniPierluigi RussoPublished in: Annals of hematology (2023)